Search UK public tenders and contract notices
Official Find a Tender notices, one row per procedure. Filters use published facts only: delivery region from the notice, buyer type from the official classification, route and vehicle as published — never a Tenderline score.
Contracts
Showing 46–60 · signed contracts with published terms.
- AwardedOpen procedureFramework21 lots
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") · NHS & health · Nationwide (UK), Scotland
This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a …
Awarded to ACCORD-UK LTD, Accord Healthcare Ltd, Aguettant Ltd +42 more · 21 awards
- Published value
- Not published
- Submit via
- portal not identified
- Published
- Reference
ocds-h6vhtk-058241
- Awarded · Open procedureFrameworkSME suitable
IV Fluids & Irrigation Solutions
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · Central government · Wales (Cymru)
Supply of IV Fluids & Irrigation Solutions
Awarded to Aguettant Ltd, B.Braun Medical Limited, Baxter Healthcare Ltd +1 more
- Published value
- £14mceiling, not a contract size
- Submit via
- Jaggaerlogin required
- Published
- Reference
ocds-h6vhtk-050594
- Awarded · Open procedureFrameworkSME suitable
NHS National Framework Agreement for Omalizumab
NHS England · Central government · North East England, North West England, East Midlands, West Midlands, East of England, South East England
Project title: NHS National Framework for Omalizumab commencing 1st February 2026 Offer reference number: CM/TNS/25/5734 Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discreti…
Awarded to Celltrion Healthcare United Kingdom Limited, Mercury Pharmaceuticals Limited, NOVARTIS PHARMACEUTICALS UK LIMITED · 2 awards
- Published value
- £86mceiling, not a contract size
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- Reference
ocds-h6vhtk-058e04
- Awarded · Open procedureFrameworkSME suitable
NHS National Framework for the supply of Tocilizumab Injection
NHS England · Central government · North East England, North West England, East Midlands, West Midlands, East of England, South East England
Project title: NHS National Framework for the supply of Tocilizumab Injection - 01 March 2026 Offer reference number: CM/TNS/25/5723 Period of framework: 1 March 2026 to 31 August 2027 with an option or options to extend (at the Authority’s…
Awarded to Celltrion Healthcare United Kingdom Limited, Fresenius Kabi Limited, Roche Products Ltd · 2 awards
- Published value
- £188mceiling, not a contract size
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- Reference
ocds-h6vhtk-059160
- Awarded · Open procedureFramework2 lotsSME suitable
NHS National Framework for Generics Housekeeping
NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England
NHS National Framework for Generics Housekeeping Offer reference number: CM/PHG/25/5733 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up…
Awarded to ACCORD-UK LTD, Alissa Healthcare Research Limited, Amarox Limited +38 more · 2 awards
- Published value
- £52mceiling, not a contract size
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- Reference
ocds-h6vhtk-058823
- Awarded · Open procedureFrameworkSME suitable
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/25/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s di…
Awarded to Aventis Pharma Ltd Trading As Sanofi, Kent Pharma Ltd, NORTHUMBRIA PHARMA LTD +5 more · 2 awards
- Published value
- £176mceiling, not a contract size
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- Reference
ocds-h6vhtk-05838e
- Awarded · Open procedureSME suitableVCSE suitable
Provision of Nasal Naloxone
Ministry of Justice · Central government · Nationwide (UK)
The provision including supply and delivery of nasal Naloxone. Nasal Naloxone supplied must be licensed for use in the UK, compliant with Medicines and Healthcare products Regulatory Agency (MHRA) standards and of a formulation licensed for…
Awarded to Orion Medical Supplies Ltd · 2 awards
- Published value
- £3.0m
- Submit via
- Jaggaerlogin required
- Published
- Reference
ocds-h6vhtk-0526b5
- AwardedSelective / two-stage
Batch manufacture of high titer/titre GMP (U.S.A.) compliant lentiviral vector for FDA approval
University Of Edinburgh · Education · Scotland
We are planning a phase I/II clinical trial to treat a rare genetic disease that causes progressive dementia in children. Our therapy will use autologous CD34+ haematopoietic stem progenitor cells (HSPCs) which are modified ex vivo with LVV…
Awarded to Indiana University
- Published value
- £900k
- Submit via
- Public Contracts Scotlandlogin required
- Published
- Reference
ocds-h6vhtk-0568ca
- Awarded · Open procedureFramework2 lotsSME suitable
NHS National Framework for Denosumab Injection commencing 1st January 2026
NHS England · Central government · North East England, North West England, Yorkshire and the Humber, East Midlands, West Midlands, East of England
Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026 Offer reference number: CM/TNS/25/5725 Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority’s…
Awarded to ACCORD-UK LTD, Amgen Ltd, Biosimilar Collaborations Ireland Limited +5 more · 2 awards
- Published value
- £57mceiling, not a contract size
- Submit via
- Atamis legacy domain (health-family.force.com)login required
- Published
- Reference
ocds-h6vhtk-05506a
- AwardedLimited / restrictedFramework
Leuprorelin (Prostap®)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Supply of Leuprorelin (Prostap®) to NHS Scotland.
Awarded to Takeda UK Limited · 2 awards
- Published value
- Not published
- Submit via
- portal not identified
- Published
- Reference
ocds-h6vhtk-05dae3
- AwardedLimited / restrictedFramework
Triptorelin (Decapeptyl®)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Supply of Triptorelin (Decapeptyl®)to NHS Scotland.
Awarded to Ipsen Ltd · 2 awards
- Published value
- Not published
- Submit via
- portal not identified
- Published
- Reference
ocds-h6vhtk-05dae5
- AwardedOpen procedureFramework4 lots
Branded and Biosimilar Ophthalmology
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.
Awarded to Bayer Plc, Biogen Idec Ltd, Celltrion Healthcare United Kingdom Limited +4 more · 4 awards
- Published value
- Not published
- Submit via
- portal not identified
- Published
- Reference
ocds-h6vhtk-058262
- AwardedOpen procedureFramework
NP40725 Erythropoietin Stimulating Agents
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Supply of Erythropoietin Stimulating Agents to NHS Scotland.
Awarded to Amgen Ltd, Pfizer Ltd, Roche Products Ltd
- Published value
- £8.6mceiling, not a contract size
- Submit via
- Public Contracts Scotlandlogin required
- Published
- Reference
ocds-h6vhtk-056a43
- AwardedLimited / restrictedFramework
NP47725a Emicizumab (Indication Specific)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS & health · Scotland
Supply of Emicizumab (Indication Specific) to NHS Scotland.
Awarded to Roche Products Ltd · 2 awards
- Published value
- Not published
- Submit via
- portal not identified
- Published
- Reference
ocds-h6vhtk-059d38
- Awarded · Open procedureFrameworkSME suitable
Transitional Drugs 4
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · Central government · Wales (Cymru)
This contract is for the provision of Transitional Drugs 4 - namely Ticagrelor and Eltrombopag
Awarded to Amarox Limited, NOVARTIS PHARMACEUTICALS UK LIMITED, Novumgen Limited
- Published value
- £4.1mceiling, not a contract size
- Submit via
- Jaggaerlogin required
- Published
- Reference
ocds-h6vhtk-054590